BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

770 related articles for article (PubMed ID: 17983645)

  • 1. Mechanisms of nongenomic actions of thyroid hormone.
    Davis PJ; Leonard JL; Davis FB
    Front Neuroendocrinol; 2008 May; 29(2):211-8. PubMed ID: 17983645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promotion by thyroid hormone of cytoplasm-to-nucleus shuttling of thyroid hormone receptors.
    Davis PJ; Davis FB; Lin HY
    Steroids; 2008 Oct; 73(9-10):1013-7. PubMed ID: 18329679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and functions of the plasma membrane receptor for thyroid hormone analogues.
    Lin HY; Cody V; Davis FB; Hercbergs AA; Luidens MK; Mousa SA; Davis PJ
    Discov Med; 2011 Apr; 11(59):337-47. PubMed ID: 21524387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular aspects of thyroid hormone actions.
    Cheng SY; Leonard JL; Davis PJ
    Endocr Rev; 2010 Apr; 31(2):139-70. PubMed ID: 20051527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translational implications of nongenomic actions of thyroid hormone initiated at its integrin receptor.
    Davis PJ; Davis FB; Lin HY; Mousa SA; Zhou M; Luidens MK
    Am J Physiol Endocrinol Metab; 2009 Dec; 297(6):E1238-46. PubMed ID: 19755667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid hormone and angiogenesis.
    Luidens MK; Mousa SA; Davis FB; Lin HY; Davis PJ
    Vascul Pharmacol; 2010; 52(3-4):142-5. PubMed ID: 19879961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nongenomic regulation by thyroid hormone of plasma membrane ion and small molecule pumps.
    Lin HY; Tang HY; Davis FB; Mousa SA; Incerpi S; Luidens MK; Meng R; Davis PJ
    Discov Med; 2012 Sep; 14(76):199-206. PubMed ID: 23021374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mini-review: Cell surface receptor for thyroid hormone and nongenomic regulation of ion fluxes in excitable cells.
    Davis PJ; Zhou M; Davis FB; Lansing L; Mousa SA; Lin HY
    Physiol Behav; 2010 Feb; 99(2):237-9. PubMed ID: 19248795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Basis of Nongenomic Actions of Thyroid Hormone.
    Davis PJ; Leonard JL; Lin HY; Leinung M; Mousa SA
    Vitam Horm; 2018; 106():67-96. PubMed ID: 29407448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane receptor for thyroid hormone: physiologic and pharmacologic implications.
    Davis PJ; Davis FB; Mousa SA; Luidens MK; Lin HY
    Annu Rev Pharmacol Toxicol; 2011; 51():99-115. PubMed ID: 20868274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid hormone is a MAPK-dependent growth factor for human myeloma cells acting via αvβ3 integrin.
    Cohen K; Ellis M; Khoury S; Davis PJ; Hercbergs A; Ashur-Fabian O
    Mol Cancer Res; 2011 Oct; 9(10):1385-94. PubMed ID: 21821675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperative nongenomic and genomic actions on thyroid hormone mediated-modulation of T cell proliferation involve up-regulation of thyroid hormone receptor and inducible nitric oxide synthase expression.
    Barreiro Arcos ML; Sterle HA; Paulazo MA; Valli E; Klecha AJ; Isse B; Pellizas CG; Farias RN; Cremaschi GA
    J Cell Physiol; 2011 Dec; 226(12):3208-18. PubMed ID: 21344381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nongenomic Actions of Thyroid Hormone: The Integrin Component.
    Davis PJ; Mousa SA; Lin HY
    Physiol Rev; 2021 Jan; 101(1):319-352. PubMed ID: 32584192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane receptors mediating thyroid hormone action.
    Davis PJ; Davis FB; Cody V
    Trends Endocrinol Metab; 2005 Nov; 16(9):429-35. PubMed ID: 16214361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoplasm-to-nucleus shuttling of thyroid hormone receptor-beta1 (Trbeta1) is directed from a plasma membrane integrin receptor by thyroid hormone.
    Cao HJ; Lin HY; Luidens MK; Davis FB; Davis PJ
    Endocr Res; 2009; 34(1-2):31-42. PubMed ID: 19557589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term effects of thyroid hormones during development: Focus on signal transduction.
    Scapin S; Leoni S; Spagnuolo S; Gnocchi D; De Vito P; Luly P; Pedersen JZ; Incerpi S
    Steroids; 2010; 75(8-9):576-84. PubMed ID: 19900468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nongenomic effects of thyroid hormones on the immune system cells: New targets, old players.
    De Vito P; Balducci V; Leone S; Percario Z; Mangino G; Davis PJ; Davis FB; Affabris E; Luly P; Pedersen JZ; Incerpi S
    Steroids; 2012 Aug; 77(10):988-95. PubMed ID: 22414628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human platelet aggregation and degranulation is induced in vitro by L-thyroxine, but not by 3,5,3'-triiodo-L-thyronine or diiodothyropropionic acid (DITPA).
    Mousa SS; Davis FB; Davis PJ; Mousa SA
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):288-93. PubMed ID: 19903697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-surface receptor for thyroid hormone and tumor cell proliferation.
    Davis PJ; Davis FB; Lin HY; Bergh JJ; Mousa S; Hercbergs A; Fenstermaker RA; Ciesielski MJ
    Expert Rev Endocrinol Metab; 2006 Nov; 1(6):753-761. PubMed ID: 30754150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid hormone stimulation of extracellular signal-regulated kinase and cell proliferation in human osteoblast-like cells is initiated at integrin alphaVbeta3.
    Scarlett A; Parsons MP; Hanson PL; Sidhu KK; Milligan TP; Burrin JM
    J Endocrinol; 2008 Mar; 196(3):509-17. PubMed ID: 18310446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.